These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2184984)

  • 1. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.
    Pfaller M; Riley J
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):152-6. PubMed ID: 1396728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.
    Pfaller M; Riley J; Koerner T
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents.
    Pfaller MA; Gerarden T
    Diagn Microbiol Infect Dis; 1989; 12(6):467-71. PubMed ID: 2696620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic.
    Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA
    J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
    Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
    J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies with terconazole.
    Isaacson DM; Foleno B; Tolman EL; Rosenthale ME
    Gynakol Rundsch; 1985; 25 Suppl 1():12-25. PubMed ID: 3891537
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
    Park KS; Kang KC; Kim JH; Adams DJ; Johng TN; Paik YK
    J Antimicrob Chemother; 1999 May; 43(5):667-74. PubMed ID: 10382888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum.
    Barrett-Bee K; Newboult L; Pinder P
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):127-31. PubMed ID: 2060756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.
    Campos Péret VA; Reis RCFM; Braga SFP; Benedetti MD; Caldas IS; Carvalho DT; Santana LFA; Johann S; Souza TB
    Eur J Med Chem; 2023 Aug; 256():115436. PubMed ID: 37146343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.
    Lees ND; Broughton MC; Sanglard D; Bard M
    Antimicrob Agents Chemother; 1990 May; 34(5):831-6. PubMed ID: 2193620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
    Marriott MS
    J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between antifungal activity and inhibition of sterol biosynthesis in miconazole, clotrimazole, and 15-azasterol.
    Taylor FR; Rodriguez RJ; Parks LW
    Antimicrob Agents Chemother; 1983 Apr; 23(4):515-21. PubMed ID: 6344784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of miconazole of the growth of Candida albicans.
    Van Den Bossche H; Willemsens G; Van Cutsem JM
    Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of the antimycotic imidazoles.
    Sud IJ; Feingold DS
    J Invest Dermatol; 1981 Jun; 76(6):438-41. PubMed ID: 7017013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.